Sendad, Amerah .

HRN: 07-53-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2025
CEFUROXIME 1.5GM (VIAL)
09/04/2025
09/06/2025
IV
1.5g
Q8hrs
Inconplete Abortion
Checking Initial Appropriateness 
09/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/06/2025
09/12/2025
IV INFUSION
500mg
Q8
Post D&C
Checking Initial Appropriateness 
09/06/2025
CEFUROXIME 1.5GM (VIAL)
09/06/2025
09/13/2025
IVT
1.5g
Q8
S/p CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: